BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16610763)

  • 1. Antiviral applications of RNAi.
    Morris KV; Rossi JJ
    Curr Opin Mol Ther; 2006 Apr; 8(2):115-21. PubMed ID: 16610763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral applications of RNAi.
    Morris KV; Rossi JJ
    Handb Exp Pharmacol; 2006; 173(173):105-16. PubMed ID: 16594613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trials.
    DeVincenzo JP
    Early Hum Dev; 2009 Oct; 85(10 Suppl):S31-5. PubMed ID: 19833462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference (RNAi) in hematology.
    Scherr M; Steinmann D; Eder M
    Ann Hematol; 2004 Jan; 83(1):1-8. PubMed ID: 14574462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA interference--significance and applications.
    Stanisławska J; Olszewski WL
    Arch Immunol Ther Exp (Warsz); 2005; 53(1):39-46. PubMed ID: 15761375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference strategies as therapy for respiratory viral infections.
    DeVincenzo JP
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S118-22. PubMed ID: 18820571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA interference for the identification of disease-associated genes.
    Nencioni A; Sandy P; Dillon C; Kissler S; Blume-Jensen P; Van Parijs L
    Curr Opin Mol Ther; 2004 Apr; 6(2):136-40. PubMed ID: 15195924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA interference as a novel and powerful tool in immunopharmacological research.
    Kong Y; Ruan L; Ma L; Cui Y; Wang JM; Le Y
    Int Immunopharmacol; 2007 Apr; 7(4):417-26. PubMed ID: 17321464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. siRNA therapeutics: big potential from small RNAs.
    Ryther RC; Flynt AS; Phillips JA; Patton JG
    Gene Ther; 2005 Jan; 12(1):5-11. PubMed ID: 15496962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
    Akhtar S; Benter I
    Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The promise, pitfalls and progress of RNA-interference-based antiviral therapy for respiratory viruses.
    DeVincenzo JP
    Antivir Ther; 2012; 17(1 Pt B):213-25. PubMed ID: 22311654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
    Takahashi Y; Nishikawa M; Takakura Y
    Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short interfering RNA (siRNA): tool or therapeutic?
    Cejka D; Losert D; Wacheck V
    Clin Sci (Lond); 2006 Jan; 110(1):47-58. PubMed ID: 16336204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The silent treatment: RNAi as a defense against virus infection in mammals.
    van Rij RP; Andino R
    Trends Biotechnol; 2006 Apr; 24(4):186-93. PubMed ID: 16503061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interfering with hepatitis C virus RNA replication.
    Randall G; Rice CM
    Virus Res; 2004 Jun; 102(1):19-25. PubMed ID: 15068876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lentivirus-mediated RNA interference therapy for human immunodeficiency virus type 1 infection.
    Morris KV; Rossi JJ
    Hum Gene Ther; 2006 May; 17(5):479-86. PubMed ID: 16716105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic application of RNA interference for hepatitis C virus.
    Watanabe T; Umehara T; Kohara M
    Adv Drug Deliv Rev; 2007 Oct; 59(12):1263-76. PubMed ID: 17822803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small RNAs and the control of transposons and viruses in Drosophila.
    van Rij RP; Berezikov E
    Trends Microbiol; 2009 Apr; 17(4):163-71. PubMed ID: 19299135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring cell type-specific internalizing antibodies for targeted delivery of siRNA.
    Liu B
    Brief Funct Genomic Proteomic; 2007 Jun; 6(2):112-9. PubMed ID: 17670766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commercial potential of RNAi.
    Jain KK
    Mol Biosyst; 2006 Nov; 2(11):523-6. PubMed ID: 17216033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.